v3.26.1
Segment Reporting (Tables)
 6 Months Ended
Jun. 30, 2026
Segment Reporting [Abstract]  
Schedule of Significant Expense Categories

The following tables present the significant expense categories reviewed by the CODM:

 

    For the Three Months Ended
June 30,		  
    2026     2025  
Research and Development            
Personnel   $ 265,815     $ 137,609  
Clinical and preclinical activities     230,875       5,662  
Other     6,330       3,630  
Total research and development     503,020       146,901  
                 
General and Administrative                
Professional services     2,819,556       268,640  
Personnel     244,065       116,922  
Corporate expenses     182,260       66,262  
Facility costs     39,600       37,501  
Total general and administrative     3,285,481       489,325  
                 
Other Segment (Income) Expenses     (16,493 )     19,717  
                 
Net Loss   $ 3,772,008     $ 655,943  

 

    For the Six Months Ended
June 30,		  
    2026     2025  
Research and Development            
Personnel   $ 428,599     $ 280,233  
Clinical and preclinical activities     246,608       29,112  
Other     9,960       7,260  
Total research and development     685,167       316,605  
                 
General and Administrative                
Professional services     3,247,071       470,128  
Personnel     390,905       189,049  
Corporate expenses     274,333       126,794  
Facility costs     76,617       75,100  
Total general and administrative     3,988,926       861,071  
                 
Other Segment Expenses     21,206       17,884  
                 
Net Loss   $ 4,695,299     $ 1,195,560